Cargando…
Interleukin-35 Suppresses Antiviral Immune Response in Chronic Hepatitis B Virus Infection
The mechanisms of hepatitis B virus (HBV) persistent infection are not completely understood. Interleukin (IL)-35, which is a newly identified cytokine belongs to IL-12 family, has been demonstrated to induce immunotolerance. Thus, the aim of current study was to investigate the role of IL-35 during...
Autores principales: | Shao, Xue, Ma, Jingting, Jia, Shengnan, Yang, Lanlan, Wang, Wudong, Jin, Zhenjing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5693856/ https://www.ncbi.nlm.nih.gov/pubmed/29181338 http://dx.doi.org/10.3389/fcimb.2017.00472 |
Ejemplares similares
-
Interleukin-35 modulates the balance between viral specific CD4(+)CD25(+)CD127(dim/-) regulatory T cells and T helper 17 cells in chronic hepatitis B virus infection
por: Yang, Lanlan, et al.
Publicado: (2019) -
Interleukin-35 Dampens CD8(+) T Cells Activity in Patients With Non-viral Hepatitis-Related Hepatocellular Carcinoma
por: Yang, Lanlan, et al.
Publicado: (2019) -
Interleukin-35 Suppresses Interleukin-9-Secreting CD4(+) T Cell Activity in Patients With Hepatitis B-Related Hepatocellular Carcinoma
por: Zhang, Qian, et al.
Publicado: (2021) -
Reduced circulating interleukin 35 is associated with enhanced peripheral T cell function in primary biliary cholangitis
por: Liu, Siqi, et al.
Publicado: (2023) -
Induction and Suppression of Innate Antiviral Responses by Hepatitis A Virus
por: Cao, Xin, et al.
Publicado: (2018)